Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MRI in the Evaluation of Acute Visual Syndromes.
I-BET151 selectively regulates IL-6 production.
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
Hospitalization rates and discharge status in multiple sclerosis.
Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases.
A case of neuromyelitis optica misdiagnosed as cervicogenic headache.
Multiple sclerosis simulating brain tumor.
Osmotic demyelination syndrome in Intensive Care Unit.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
Intractable pruritus in neuromyelitis optica.
Retinal periphlebitis is associated with multiple sclerosis severity.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Agent Orange Exposure and Prevalence of Self-reported Diseases in Korean Vietnam Veterans.
Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis.
Therapeutic potential of cannabinoid medicines.
Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis.
Neurogenic detrusor overactivity: an update on management options.
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
Efficacy of Fish Oil on Serum of TNF α , IL-1 β , and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b.
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes.
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
Pathogenesis of immune-mediated neuropathies.

Pages